ARTERIAL HYPERTENSION AND THE MOST PREVALENT CARDIOVASCULAR RISK FACTORS (from the XIX Scientific Congress of the International Association of Arterial Hypertension and the XII European Congress on Arterial Hypertension)
Abstract
Arterial hypertension and the most prevalent cardiovascular risk factors (from the XIX Scientific Congress of the International Association of Arterial Hypertension and the XII European Congress on Arterial Hypertension).
About the Authors
E. Y. MaychukRussian Federation
O. A. Vasilevitskaya
Russian Federation
I. B. Pechenkina
Russian Federation
A. I. Martynov
Russian Federation
References
1. Agrati AM, Ferraro G, Colafrancesco M et al. Ambulatory blood pressure monitoring in the diagnosis of classical and ambulatory white coat hypertension. J. of Hypertension Vol. 20 (Suppl. 4), June 2002, P. S232.
2. Pickering T.G., Davidson K.W., Rafey M. et al. Masked hypertension: are those with normal office but elevated ambulatory blood pressure at risk? P. S176 ibid.
3. Celis H., Staessen J.A., Thijs L. et al. Cardiovascular risk in white-coat and sustained hypertensive patients. P. S256 ibid.
4. Pierdomenico S.D., Bucci A., Lapenna D. et al. Circulating homocysteine levels in sustained and isolated clinic hypertension. P. S237 ibid.
5. Hermida R.C., Calvo C., Ayala D.E. et al. Differences in the circadian variation of blood pressure between normotensive and white coat hypertensive subjects. P. S227 ibid.
6. Stergiou G.S., Efstathiou S.P., Argyraki C.K. et al. Clinic, home and ambulatory pulse pressure: comparison and reproducibility. P. S231 ibid.
7. A. Basset, D. Laude, S. Laurent et al. Circadian rhythms of blood pressure and heart rate in three inbred rat strains: dipper and non-dipper status. P. S258 ibid.
8. M.L. Muiesan, M. Salvetti, C. Monteduro et al. Cardiovascular structure in patients with isolated office of ambulatory hypertension (the VOBARNO study) P. S314 ibid.
9. Denolle T., Gallois H., L’Hostis P. et al. Decision of treatment in relation to cardiovascular risk in isolated systolic hypertension in general practice: PREHSI study. P. S320 ibid.
10. Denolle T., Gallois H., L’Hostis P. et al. Characteristics of patients with isolated systolic hypertension in relation to body mass index: PREHSI study. P. S319 ibid.
11. Catena C., Giagu P., Novello M. et al. Association of hyperinsulinemia with fibrinogen levels and activated coagulation in hypertension. P. S60 ibid.
12. Kabat M., Peczkowska M., Januszewicz A. et al. Blood pressure variability, metabolic profile and target organ damage in hypertensive patients P. S65 ibid.
13. Takaoka M., Yamano S., Yamamoto Y. et al. Association between circulating oxidized low density lipoprotein levels and carotid atherosclerosis in patients with essential hypertension. P. S142 ibid.
14. Iguchi S., Morishita R., Aoki M. et al. Acceleration of neointimal hyperplasia in Lp(a) transgenic mice: contribution of Lp(a) in the pathogenesis of vascular disease. P. S138 ibid.
15. Nanchahal K. Association of pulse pressure with predicted risks of coronary heart disease and stroke. P. S320 ibid.
16. Staessen J.S., Thijs L.S., O’Brien E.T. et al. Ambulatory pulse pressure - not mean pressure - determines outcome in older patients with systolic hypertension. P. S74 ibid.
17. Katsahian S., Laloux B., Boutouyrie P. et al. Arterial stiffness and primary stroke in french hypertensive patients. P. S255 ibid.
18. Gariepy J., Chironi G., Denarie N. et al. Comparative values of noninvasive ultrasound markers of early atherosclerosis as regards cardiovascular risk. P. S67 ibid.
19. Kita T., Kitamura K., Kato J. et al. Adrenomedullin is a useful indicator of arterial sclerosis. P. S136 ibid.
20. Saitoh S., Takagi S., Ohata J. et al. An epidemiological crosssectional study on the relationships between atherosclerosis, pulse pressure and the high-sensitivity C-reactive protein. P. S139 ibid.
21. Cifkova R., Frohlich J., Novozamska E. et al. Female but not male hypertensives have elevated C-reactive protein. A population-based study. P. S177 ibid.
22. Kohara K., Tabara Y., Yamamoto Y. et al.Chlamydia pneumoniae infection is associated with increased plasma levels of soluble cellular adhesion molecules in community-dwelling subjects. P. S68 ibid.
23. Matsuoka H., Sugano R., Fukami K. et al. Body iron store is associated with subclinical atherosclerosis: role of insulin resistance and oxidative stress. P. S62 ibid.
24. Sugano R., Matsuoka H., Murase E. et al. Endogenous NO synthase inhibitor as a novel risk factor for atherosclerosis in humans: role of oxidative stress. P. S271 ibid.
25. Mohteshamzadeh M., Thomas S.H.L., Wilkinson R. et al. Exposure of red blood cells to nitric oxide in hypertension. P. S101 ibid.
26. Vinnik T.A., Tolstova I.A., Vakhrameeva N.V. et al. Endothelium-dependent vasodilatation in patients with essential hypertension. P. S265 ibid.
27. Mackenzie I.S., Cockcroft J.R., Hall I.R. et al. Assessment of endothelial function using pulse wave analysis. P. S267 ibid.
28. Cifkova R., Skodova Z., Lanska V. et al. Gender differences in the prevalence, awareness, treatment and control of hypertension in the czech population. P. S326 ibid.
29. Starmans-Kool M.J., Balkestein E.J., Staessen J.A. et al. Effect of gender on age-related changes in pulse pressure. P. S176 ibid.
30. Miyagi T., Muratani H., Sakima A. et al. Contribution of diabetes mellitus and low hdl-cholesterol to the elevation of pulse pressure varies with sex and age class. P. S136 ibid.
31. Hakamada-Taguchi R., Uehara Y., Negoro H. et al. Cognitive function in healthy middle-aged women is determined by systolic blood pressure within a normotensive range. P. S145 ibid.
32. Bystrova M.M., Britov A.N., Gorbunov V.M. et al. The dual effect of menopause on hemodynamic and metabolic profile in hypertensive women. P. S78 ibid.
33. Harvey P.J., Kubo T., Su W. et al. Augmentation of flow mediated vasodilation after acute exersise and chronic estrogen replacement in post-menopausal normotensive women. P. S335 ibid.
34. Suzuki H., Kanno Y., Kobayashi K. et al. Pulse pressure is an important factor in determination of the choice of antihypertensive drugs in postmenopausal women. P. S235 ibid.
35. Wang J.G., Staessen J.A., Barlassina C. et al. Association between hypertension and polymorphisms in the α- and β- adducin genes in a white population. P. S7, ibid.
36. Sugimoto K., Katsuya T., Hozawa A. et al. C3123a polymorphism of angiotensin ii type 2 receptor gene is associated with hypertension in younger female: the OHASAMA study. P. S21 ibid.
37. Bicho M., Coelho C., Breitenfeld L. et al. Association study of ace genotype and its biochemical phenotype with obesity and insulin resistance in normotensive postmenopausal women. P. S207 ibid.
38. Benjafield A.V., Wang W.Y.S., Nyholt D.R. et al. Genome scan for essential hypertension. P. S24 ibid.
Review
For citations:
Maychuk E.Y., Vasilevitskaya O.A., Pechenkina I.B., Martynov A.I. ARTERIAL HYPERTENSION AND THE MOST PREVALENT CARDIOVASCULAR RISK FACTORS (from the XIX Scientific Congress of the International Association of Arterial Hypertension and the XII European Congress on Arterial Hypertension). Russian Journal of Cardiology. 2002;(5):91-96. (In Russ.)